Literature DB >> 21165682

A new stochastic approach to multi-compartment pharmacokinetic models: probability of traveling route and distribution of residence time in linear and nonlinear systems.

Liang Zhao1, Na Li, Harry Yang.   

Abstract

Drug kinetics in human has been studied from both deterministic and stochastic perspectives. However, little research has been done to systematically determine the probability for a drug molecule to follow a specific traveling route. Recently a method was developed to estimate this probability and the probability density function of residence time in linear systems. In this paper, we provide a rigorous proof of the main results of the previous paper and extend the method to nonlinear multi-compartment systems. A novel concept of compartment expansion is introduced to facilitate the development of our method. This formulation resolves computational difficulties associated with nonlinear systems, allowing for direct estimation of the probability intensity coefficients, and subsequently the transition probability and probability density function of the residence time. With such expansion of the methodology, it becomes both practical and feasible to apply it in the real-world drug development where drug disposition patterns are often nonlinear. The method can be used to estimate drug exposure at any site of interest, thus may help us to gain better understanding about the impact of drug exposure on efficacy and safety.

Entities:  

Mesh:

Year:  2010        PMID: 21165682     DOI: 10.1007/s10928-010-9179-8

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  21 in total

1.  A general approach to non-Markovian compartmental models.

Authors:  J H Matis; T E Wehrly
Journal:  J Pharmacokinet Biopharm       Date:  1998-08

2.  The development of a stochastic physiologically-based pharmacokinetic model for lead.

Authors:  B D Beck; R L Mattuck; T S Bowers; J T Cohen; E O'Flaherty
Journal:  Sci Total Environ       Date:  2001-07-02       Impact factor: 7.963

3.  An approach to the residence time distribution for stochastic multi-compartment models.

Authors:  Jihnhee Yu; Thomas E Wehrly
Journal:  Math Biosci       Date:  2004-10       Impact factor: 2.144

4.  Using stochastic differential equations for PK/PD model development.

Authors:  Niels Rode Kristensen; Henrik Madsen; Steen Hvass Ingwersen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-02       Impact factor: 2.745

5.  Nonlinear stochastic modeling of aphid population growth.

Authors:  James H Matis; Thomas R Kiffe; Timothy I Matis; Douglass E Stevenson
Journal:  Math Biosci       Date:  2005-09-23       Impact factor: 2.144

6.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

Authors:  L B Sheiner; D R Stanski; S Vozeh; R D Miller; J Ham
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

7.  Pharmacokinetic model to describe the lymphatic absorption of r-metHu-leptin after subcutaneous injection to sheep.

Authors:  Danielle N McLennan; Christopher J H Porter; Glenn A Edwards; Maria Brumm; Steven W Martin; Susan A Charman
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

8.  Effect of interferon-alpha-2a on the output of recirculating lymphocytes from single lymph nodes.

Authors:  W R Hein; A Supersaxo
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

9.  Pharmacokinetic analysis of ramatroban using a recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference in Sprague-Dawley and Eisai hyperbilirubinemic rats.

Authors:  Toshiya Moriwaki; Hiroyuki Yasui; Akira Yamamoto
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

10.  Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice.

Authors:  Amit Garg; Joseph P Balthasar
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-07-18       Impact factor: 2.745

View more
  2 in total

Review 1.  Clinical pharmacology considerations in biologics development.

Authors:  Liang Zhao; Tian-hua Ren; Diane D Wang
Journal:  Acta Pharmacol Sin       Date:  2012-09-24       Impact factor: 6.150

2.  Development of a Pharmacokinetic Model Describing Neonatal Fc Receptor-Mediated Recycling of HL2351, a Novel Hybrid Fc-Fused Interleukin-1 Receptor Antagonist, to Optimize Dosage Regimen.

Authors:  Lien Ngo; Jaeseong Oh; Anhye Kim; Hyun-Moon Back; Won-Ho Kang; Jung-Woo Chae; Hwi-Yeol Yun; Howard Lee
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-10-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.